Healthcare Highlights: Pfizer Inc. (NYSE:PFE) Drug Shows Positive Results against Breast Cancer, Lpath, Inc. (NASDAQ:LPTN) Gets Patent Another from EPO

  on Dec 06,2012 Posted in Business News ,U.S. News
Share |
We're on   

Lpath, Inc. (NASDAQ :LPTN), the Biotech lipid-targeted therapeutics industry leader, got official notice from European Patent Office (EPO) that the firm has been allotted a key patent covering monoclonal antibodies against sphingosine-1-phosphate (S1P), containing sonepcizumab™. S1P is a bioactive lipid that has been authorized as a mark in different disease states.

Shares of Lpath, Inc. (NASDAQ:LPTN) moved up +1.67% and closed at $6.10 with the total traded volume of 12,951 shares. Stock opened at $6.00 and its shares were trading within the range of $6.00-$6.20. LPTN has earnings per share of $40.08.

Pfizer Inc. (NYSE:PFE)’s trial breast cancer medicine halted development of an incurable kind of the disease for over two years in a study, an affected interruption for those with the second-deadliest cancer in women.

Pfizer Inc. (NYSE:PFE) gained +1.89% with the closing price of $25.64. The overall volume in the last trading session was 45.53 million shares. Its fifty two week range was $19.95-$26.09. The total market capitalization remained $188.78 billion.

PFE is ahead of its 52 week low with 35.06% and its last month’s price volatility remained 1.47%. Its beta coefficient was 0.71 with a target price of $27.53. Company’s current year earnings per share grew with 9.08% while the five years EPS growth rate was -6.12%.

Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) reported on Wednesday that the company has hit a deal with the US Food and Drug Administration on the design of a Phase III trial of its cure for recurring brain cancer.

In last trading session, Peregrine Pharmaceuticals(NASDAQ:PPHM) dropped-0.78% and closed at $1.28 with the total traded volume of 9.11 million shares. It has outstanding shares of 104.19million with the total market capitalization of $133.36million and its beta value stands at 0.67 times. PPHM has current ratio of 1.05.

With the latest rise of +0.16%, Johnson & Johnson (NYSE:JNJ) now has YTD performance +10.64% which for the week is positive at 0.98%. Apple pays a dividend yield of 3.49%. The company will report lower sales for the Quarter ending Dec-12, according to 15 analysts polled by Reuters. On average, they believe sales will arrive at $17,688.70 from $17,234.00 posted in the same quarter last year. The average sales forecast of 19 analysts for the full-year is $67,339.20, down as compared to $67,840.40 annual sales a year ago.

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock with a +0.70% gain to $8.68 in the latest trading session has changed its distance from 200-Day Moving Average to +28.47% and 50-Day Moving Average to -0.03%. It captures $1.89 billion in market value. The mean rating 2.90 is set by analysts. The company is projected to report $0.05 per share for the quarter ending Dec-12 as compared to -$0.13 earned a year earlier, according to 10 analysts surveyed by Reuters. The average EPS forecast of 9 analysts for the full-year is -$0.29, down as compared to -$0.36 earned a year ago.



Leave a Reply